In HCC, PBK mediates oxaliplatin resistance by regulating PTEN, while in ovarian cancer, PBK interacts with TRIM37 to promote PARPi resistance in ovarian cancer 148, 149. This evidence concerns the gene PBK and ovarian cancer.